Seres Therapeutics, Inc. (MCRB) Stock Investment Calculator & Historical Return Analysis
Seres Therapeutics, Inc. (MCRB) is a major public corporation operating in global financial and commercial markets. The company designs, produces, and markets key products, services, and operational solutions for consumer, enterprise, and industrial customers. Through continuous strategic investments in research, operational scaling, and market expansion, Seres Therapeutics, Inc. maintains a prominent position within its industry sector. Investors often view Seres Therapeutics, Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This Seres Therapeutics, Inc. stock investment calculator allows you to explore how a hypothetical investment in MCRB might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in MCRB on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding Seres Therapeutics, Inc.'s Historical Performance
Seres Therapeutics, Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, MCRB has experienced periods of growth driven by innovation and market demand.
When analyzing Seres Therapeutics, Inc.'s historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 12 years, Seres Therapeutics, Inc. has delivered an annualized return (CAGR) of -36.6%. Its strongest year was 2020 at +631.3%, and its weakest was 2023 at -74.1%. Overall, the stock finished in the green 2 times out of 12 years.
Annualized
-36.6%
Win Rate
17%
2W - 10L
Best
+631.3%
2020
Worst
-74.1%
2023
Performance Consistency
Seres Therapeutics, Inc. Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2015 | -31.73% | $1028.00 | $701.80 |
| 2016 | -70.97% | $682.00 | $198.00 |
| 2017 | +1.30% | $200.20 | $202.80 |
| 2018 | -57.16% | $211.00 | $90.40 |
| 2019 | -28.57% | $96.60 | $69.00 |
| 2020 | +631.34% | $67.00 | $490.00 |
| 2021 | -66.76% | $501.20 | $166.60 |
| 2022 | -36.65% | $176.80 | $112.00 |
| 2023 | -74.07% | $108.00 | $28.00 |
| 2024 | -40.64% | $28.00 | $16.62 |
| 2025 | -11.74% | $16.86 | $14.88 |
| 2026 | -67.00% | $15.15 | $5.00 |
Historical annual returns for Seres Therapeutics, Inc.. Each year shows the change from that year's first trading day to its last, using split- and dividend-adjusted closing prices. The current year is partial (year-to-date).
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Ecobiotic® drugs
- ✓Integration of advanced data analytics and automation into core operational workflows.
- ✓VOWST™ (first FDA-approved oral microbiome therapeutic)
- ✓Proprietary technology architecture developed by Seres Therapeutics, Inc. to optimize operational performance.
- ✓Strategic R&D investment driving next-generation solution design and market differentiation.
- ✓Expansion of digital transformation initiatives across product engineering and customer delivery.
Business Segments
- TherapeuticsDevelopment of microbiome therapeutics.
- Global Services & SupportComprehensive customer success, maintenance, and ongoing operational support services.
- Global Support & InfrastructureEnterprise administrative, technological, and customer maintenance services.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can show how an investment behaved across different market cycles.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles